Home > Inhibitors & Agonists > Autophagy
Cat. No. Product name CAS No.
DC11964 Lys01

A 10-fold more potent lysosomal autophagy inhibitor than hydroxychloroquine (HCQ)..

391426-22-4
DC11603 SR-19871

A novel potent ULK1 inhibitor with IC50 of 11 nM..

DC11668 AUTEN-67

A small molecule autophagy enhancer that specificly inhibits myotubularin-related phosphatase MTMR14.

1783800-77-0
DC11965 Lucanthone

An orally available thioxanthone-based DNA intercalator and inhibitor of the DNA repair enzyme apurinic-apyrimidinic endonuclease 1 (APE1) potential antineoplastic activity, also inhibits autophagy.

479-50-5
DC10824 ARN-3236 Featured

ARN-3236 is potent, orally active and selective SIK2 inhibitor. ARN-3236 inhibited the growth of 10 ovarian cancer cell lines at an IC50 of 0.8 to 2.6 μmol/L.

1613710-01-2
DC10548 Auten-99 Featured

Auten-99 is a novel inhibitor of the myotubularin phosphatase Jumpy (also called MTMR14), acrossing the blood-brain barrier and exerting potent neuroprotective effects.

1049780-58-6
DC8730 Cambendazol Featured

Cambendazol is an antihelmintic that, at a dose of 50 mg/kg/day in mice, eradicates S. ratti adult worms from intestine and S. stercoralis larva from muscle.

26097-80-3
DC7113 CZC-25146 Featured

CZC-25146 is a potent, selective and metabolically stable LRRK2 inhibitor with IC50 of 4.76 nM/6.87 nM for wild type LRRK2 and G2019S LRRK2 respectively.

1191911-26-8
DC8082 CZC-54252 Featured

CZC-54252 is a potent inhibitor of leucine-rich repeat kinase 2 (LRRK2) (IC50 values are 1.28 nM and 1.85 nM for wild-type and G2019S mutant forms of LRRK2 respectively).

1191911-27-9
DC7404 DMXAA

DMXAA (Vadimezan) is a vascular disrupting agents (VDA) and competitive inhibitor of DT-diaphorase with Ki of 20 μM and IC50 of 62.5 μM, respectively. Phase 3.

117570-53-3
DC10194 FMK 9a

FMK 9a is an autophagin-1 inhibitor with IC50 values of 80 and 73 μM in FRET and LRA assay.

1955550-51-2
DC7418 GNE-0877

GNE0877 is a highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitor with an IC50 of 3 nM.

1374828-69-9
DC7419 GNE-7915 Featured

GNE-7915 is a highly potent, selective, and brain-penetrable LRRK2 small molecule inhibitor with IC50 of 9 nM in cellular LRRK2 assay; > 100 fold selectivity against a panel of 187 kianses(Ki).

1351761-44-8
DC7629 GNE-9605 Featured

GNE-9605 is a highly potent and selective Leucine-rich repeat kinase 2 (LRRK2) inhibitor

1536200-31-3
DC7852 LRRK2 inhibitor GSK2578215A Featured

GSK2578215A is a potent and highly selective LRRK2 inhibitor; exhibits IC50s of around 10 nM against both wild-type LRRK2 and the G2019S mutant.

1285515-21-0
DC8648 Rev-erbα agonist GS4112

GSK4112 is a Rev-erbα agonist with EC50 of 0.4 μM, also is a small molecule chemical probe for the cell biology of the nuclear heme receptor Rev-erbα.

1216744-19-2
DC11258 IITZ-01 Featured

IITZ-01 is a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo.

1807988-47-1
DC8379 JH-II-127 Featured

JH-II-127 is a highly potent, selective, and brain penetrant LRRK2 inhibitor.

1700693-08-8
DC11440 LRRK2 inhibitor 18

LRRK2 inhibitor 18(Compound 18) is a potent azaindazole leucine-rich repeat kinase 2 (LRRK2) inhibitor with Ki of 4.1 nM.

1459257-24-9
DC8237 LRRK2-IN-1 Featured

LRRK2-IN-1 inhibits both wild-type and G2019S mutant LRRK2 kinase activity with IC50 values of 13 nM and 6 nM , respectively with 0.1 mM ATP in the assay.

1234480-84-2
DCAPI1570 Hydroxychloroquine Sulphate

Lupus erythematosus suppressant as well as an antimalerial and antirheumatic.

747-36-4
DC11172 LV-320

LV-320 (LV320) is a novel potent, cell-active, allosteric inhibitor of the autophagy-related cysteine protease ATG4B with IC50 of 24.5 uM in ATG4B cleavage assays.

Page 1 / Total 3 FirstPrevNextLastGoto